Narrative review / 2014
A review concludes that calcium supplements provide little fracture prevention benefit while likely increasing risks of adverse events.
This review evaluates the role of calcium supplements in osteoporosis prevention. While calcium acts as a weak antiresorptive and slows postmenopausal bone loss, recent meta-analyses indicate no significant prevention of fractures. Meanwhile, supplement use is likely associated with increased cardiovascular events, kidney stones, gastrointestinal symptoms, and hospital admissions for acute gastrointestinal issues. Consequently, the review suggests obtaining calcium from dietary sources instead, noting that dietary calcium has not been linked to the adverse effects seen with supplements.
- Study type
- Narrative review
- Who was studied
- Individuals at risk for osteoporosis / postmenopausal women
- What was measured
- Fracture prevention, bone loss, and adverse events including cardiovascular events and kidney stones
THE PAPER
Should we prescribe calcium supplements for osteoporosis prevention?
Reid IR. J Bone Metab, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.